Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Gilenya (Fingolimod) - Important Safety Information from Novartis as approved by the Irish Medicines Board 30.01.2013
Notice type:
3rd Party Publications
Date:
30/01/2012
Problem Or Issue:
Important Safety Information from Novartis Ireland Ltd regarding Gilenya (Fingolimod) on strengthening the cardiovascular monitoring during treatment initiation in patients with Relapsing Remitting Multiple Sclerosis.
Important Safety Information - Gilenya (Fingolimod)
« Back
Date Printed: 20/05/2024